Todavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Historial de señales
Explore the complete record of transactions filed by Lippis Daniel J., CVP, JAPAC. Director active across 1 company, notably Edwards Lifesciences Corp. Cumulatively, 34 reports have been published. Split: 0 buy · 4 sells. Total volume traded: €381k. Activity tracked since 16 February 2024. The latest transaction was filed on 11 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lippis Daniel J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2500 títulos@ 45,2767 US$13.9% de su flujoCommon StockSEC:0001225208-24-010858:0
25 de 34 declaraciones
About Lippis Daniel J.
Lippis Daniel J. is CVP, JAPAC and appears in 32 filings in total. In the recent filings tracked from 2024-02-20 to 2026-07-10, the visible amounts are all sales, totaling EUR 331471, and the most common transaction nature is option exercise.